Melanoma, An Issue of Surgical Oncology Clinics of North America
- 1st Edition, Volume 34-3 - May 29, 2025
- Latest edition
- Editor: Genevieve Boland
- Language: English
In this issue of Surgical Oncology Clinics, guest editor Dr. Genevieve Boland brings her considerable expertise to the topic of Melanoma. Top experts provide a timely update on man… Read more
Purchase options
In this issue of Surgical Oncology Clinics, guest editor Dr. Genevieve Boland brings her considerable expertise to the topic of Melanoma. Top experts provide a timely update on management of melanoma, with articles on nodal management, stage 4 surgery, margins, systemic therapy, and neoadjuvant therapy, as well as vaccines in melanoma and ocular and mucosal melanoma.
- Contains 10 relevant, practice-oriented topics including margins for melanoma: alternative approaches (Mohs), extent of resection (lentigo maligna MIS, SSM, Melmart), and future considerations; age and gender correlations with melanoma outcomes; systemic therapy for melanoma: what surgeons need to know; is nodal staging needed, what is the value, and what is the extent of surgery?; and more
- Provides in-depth clinical reviews on melanoma, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Surgical oncologists
Margins for Melanoma: Extent of Resection, Alternative Approaches, and Future Considerations
Age and Sex Correlations with Melanoma Outcomes (Nodal Status, Survival Melanoma in Pregnancy, and Spitzoid Lesions)
Nodal Management in Melanoma: Is Nodal Staging Needed, What Is the Value, and What Is the Extent of Surgery?
Systemic Therapy for Melanoma: What Surgeons Need to Know
Neoadjuvant Therapy: Changes in the Management of Macroscopic Stage III/ Resectable Stage IV Melanoma
Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic Therapy
Vaccines in Melanoma: Past, Present, and Future
Adoptive T-Cell Therapy in Melanoma: How This Will Impact Surgical Practice and the Role of Surgeons
Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy in Advanced Melanomas
Non-Cutaneous Melanoma: Biology, Clinical Management, Current Therapy, and Future Directions in Treatment
Age and Sex Correlations with Melanoma Outcomes (Nodal Status, Survival Melanoma in Pregnancy, and Spitzoid Lesions)
Nodal Management in Melanoma: Is Nodal Staging Needed, What Is the Value, and What Is the Extent of Surgery?
Systemic Therapy for Melanoma: What Surgeons Need to Know
Neoadjuvant Therapy: Changes in the Management of Macroscopic Stage III/ Resectable Stage IV Melanoma
Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic Therapy
Vaccines in Melanoma: Past, Present, and Future
Adoptive T-Cell Therapy in Melanoma: How This Will Impact Surgical Practice and the Role of Surgeons
Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy in Advanced Melanomas
Non-Cutaneous Melanoma: Biology, Clinical Management, Current Therapy, and Future Directions in Treatment
- Edition: 1
- Latest edition
- Volume: 34-3
- Published: May 29, 2025
- Language: English
GB
Genevieve Boland
Affiliations and expertise
Vice Chair of Research, Department of Surgery, Mass General Surgery: Surgical Oncology, Yawkey Center for Outpatient Care, Boston, MA, USA